Investor News

Confo Therapeutics – Unlocking the power of GPCRs

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-based Biotherapeutic Product Pipeline

Spica Therapeutics Secures €1 Million VLAIO Grant to Advance Groundbreaking Macrophage-Targeted Cancer Therapy

Animab Secures EUR 10 Million in Series B Financing to Launch Nanoprotec® in Europe and Expand Pipeline

Spica Therapeutics Closes €10 Million Seed Round to Advance Macrophage-Targeted Therapies

Lever Bio Announces a €4 Million Financing Round and a Strategic Partnership with VIB to Advance Four Novel Immuno-Oncology Assets

Orionis Biosciences Announces Strategic Partnership with Genentech to Discover and Develop Molecular Glue Class Medicines for Cancer

VIB launches new Agtech spin-off Rainbow Crops to develop climate-resilient crop varieties

VIB Delivers 12-Fold Economic Return to Flanders, Independent Study Confirms

Animab enters into an exclusive distribution agreement with Huvepharma to commercialise Nanoprotec® for ETEC protection in piglets in Europe

Transforming disease control in piglets with an antibiotic-free monoclonal antibody solution

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

Revolutionizing Protein Crop Cultivation in Europe